Inflection Biosciences

0 followers

‌

Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major unmet needs in cancer.

Industries

Headquarters

Employees

Links

Org chart

Darren Cunningham

CEO and Co-Founder

Darren Cunningham

Collapse

Tess Barker

Head of Development

Frank Bonner

Head of Non-Clinical Safety

Gemma Carroll

Financial Controller

Kathy Gately

Senior Scientist (Translational Oncology)

Paul Dickinson

CMC: Preclinical and Clinical Formulation Development

David Lathbury

CMC: Process Chemistry

Gerry McGettigan

Regulatory Affairs

Teams

+10

Regulatory Affairs

13 members

Scientific Research and Development

3 members

Similar companies

EpimAb Biotherapeutics

1 follower

Thermo Fisher Scientific

143 followers

Gilead Sciences

121 followers

Biogen

108 followers

Regeneron

89 followers

Agilent Technologies

61 followers

Vertex Pharmaceuticals

50 followers

CSL

37 followers

Alexion Pharmaceuticals

33 followers

GRAIL

27 followers

Lonza

27 followers

Discover companies